NEU 3.15% $21.27 neuren pharmaceuticals limited

Share Price, page-10090

  1. 1,539 Posts.
    lightbulb Created with Sketch. 131
    There aren't a lot of good comparisons on the ASX. COH is probably the best, despite being a device company. It is a mature company that is still growing modestly but affords a 46 forward earnings ratio. CSL is hardly growing at all, and still gets a 30 PE due to the industry they're in. TLX I am not sure if they have made a profit yet but google indicates their PE is 957 so I am unsure how accurate that is, but that's a growth story.

    COH
    3 Year Revenue Growth 13%
    Cochlear Ltd (ASX:COH) Valuation | Morningstar
    Forward PE 46

    CSL
    Net Income Growth (3 years) 1.43%
    Forward PE 30

    TLX
    3 Year Revenue Growth 373%
    Forward PE 66.67

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$21.27
Change
0.650(3.15%)
Mkt cap ! $2.718B
Open High Low Value Volume
$20.84 $21.56 $20.76 $7.760M 364.5K

Buyers (Bids)

No. Vol. Price($)
2 1378 $21.24
 

Sellers (Offers)

Price($) Vol. No.
$21.29 218 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.